ArticleFrontiers in digital health2026
Exploring medication experiences, behaviours, and reminder technology preferences in people with Parkinson's disease: a survey.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Introduction: Due to complex medication regimens, suboptimal medication adherence is common among people with Parkinson's disease (PwP), leading to poor symptom control. Medication reminder technology, and a deeper understanding of individual's medication experiences and behaviours offer promising solutions, but these factors need to be explored in PwP. An online survey was developed to identify the current potential use of medication reminder technology in PwP; determine the essential features of the ideal medication reminder technology; compare feature preferences between current medication reminder technology users and non-users; and Explore Respondents Medication Experiences and Behaviour. Methods: The survey was open to individuals over 18, with a PD diagnosis and taking oral PD medication. The survey consisted of 51 primary questions exploring PwP medication experiences and behaviours; current/potential use of medication reminder technology; and designing ideal medication reminder technology. Descriptive statistics, and statistical tests compared questionnaire responses. To categorise free-text responses, inductive and deductive content analysis was performed. Results: Data from 283 PwP (median age: 65 years, 46% female) was analysed. Thirty-four percent were non-adherent to their PD medication regimen, and respondents with more negative medication beliefs and perceived medication complexity had worse medication adherence. Fifty percent of respondents already used medication reminder technology, with these respondents most commonly using smartphones (72%). Respondents who already used medication reminder technology scored significantly higher on the medication adherence rating scale (MARS-5). When choosing the ideal medication reminder technology, smartwatches were the preferred device (57%). When designing the ideal medication reminder smartwatch, no features were deemed 'essential' to all respondents, with great heterogeneity in preferences. Overall, smartwatch usability and functionality was more important to respondents than appearance, and current users of reminder technology placed greater importance on smartwatch usability than non-users. Discussion: Medication reminder technology, such as smartwatches, may support medication adherence in PwP, but this technology must be personalised to user needs, and developed with an emphasis on usability and functionality, over aesthetics. When developing this technology, PwP should be included as co-developers, and the process should be iterative. However, reminder technology alone may not sufficiently support adherence, and additional patient-related factors need to be overcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.